JP7170634B2 - Ｉｒａｋ阻害剤としての使用のためのオキサゾール誘導体およびその調製のための方法 - Google Patents

Ｉｒａｋ阻害剤としての使用のためのオキサゾール誘導体およびその調製のための方法 Download PDF

Info

Publication number
JP7170634B2
JP7170634B2 JP2019522385A JP2019522385A JP7170634B2 JP 7170634 B2 JP7170634 B2 JP 7170634B2 JP 2019522385 A JP2019522385 A JP 2019522385A JP 2019522385 A JP2019522385 A JP 2019522385A JP 7170634 B2 JP7170634 B2 JP 7170634B2
Authority
JP
Japan
Prior art keywords
pyrazol
oxazole
carboxamide
compound
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019522385A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019537577A (ja
JP2019537577A5 (https=
Inventor
ホイ リー
ティロ ヘックロード
ヤン チェン
ライアン ケリー
ダレン マクマツリー
キン ツォ
バネッサ タイラー
ラジンダー シング
ローズ イェン
ジャック マウン
Original Assignee
ライジェル ファーマシューティカルズ， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ライジェル ファーマシューティカルズ， インコーポレイテッド filed Critical ライジェル ファーマシューティカルズ， インコーポレイテッド
Publication of JP2019537577A publication Critical patent/JP2019537577A/ja
Publication of JP2019537577A5 publication Critical patent/JP2019537577A5/ja
Priority to JP2022175223A priority Critical patent/JP7379640B2/ja
Application granted granted Critical
Publication of JP7170634B2 publication Critical patent/JP7170634B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2019522385A 2016-10-26 2017-10-25 Ｉｒａｋ阻害剤としての使用のためのオキサゾール誘導体およびその調製のための方法 Active JP7170634B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022175223A JP7379640B2 (ja) 2016-10-26 2022-11-01 Ｉｒａｋ阻害剤としての使用のためのオキサゾール誘導体およびその調製のための方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662413217P 2016-10-26 2016-10-26
US62/413,217 2016-10-26
PCT/US2017/058339 WO2018089199A1 (en) 2016-10-26 2017-10-25 Oxazole derivatives for use as irak inhibitors and method for their preparation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022175223A Division JP7379640B2 (ja) 2016-10-26 2022-11-01 Ｉｒａｋ阻害剤としての使用のためのオキサゾール誘導体およびその調製のための方法

Publications (3)

Publication Number Publication Date
JP2019537577A JP2019537577A (ja) 2019-12-26
JP2019537577A5 JP2019537577A5 (https=) 2020-12-03
JP7170634B2 true JP7170634B2 (ja) 2022-11-14

Family

ID=60302473

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019522385A Active JP7170634B2 (ja) 2016-10-26 2017-10-25 Ｉｒａｋ阻害剤としての使用のためのオキサゾール誘導体およびその調製のための方法
JP2022175223A Active JP7379640B2 (ja) 2016-10-26 2022-11-01 Ｉｒａｋ阻害剤としての使用のためのオキサゾール誘導体およびその調製のための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022175223A Active JP7379640B2 (ja) 2016-10-26 2022-11-01 Ｉｒａｋ阻害剤としての使用のためのオキサゾール誘導体およびその調製のための方法

Country Status (9)

Country Link
US (4) US10370367B2 (https=)
EP (1) EP3532470B1 (https=)
JP (2) JP7170634B2 (https=)
CN (1) CN110099899B (https=)
CA (1) CA3041587A1 (https=)
DK (1) DK3532470T3 (https=)
ES (1) ES2939232T3 (https=)
PT (1) PT3532470T (https=)
WO (1) WO2018089199A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110862375B (zh) * 2018-08-27 2022-10-25 深圳铂立健医药有限公司 吡唑化合物及其药物组合物和应用
BR112022001418A2 (pt) * 2019-08-08 2022-06-07 Rigel Pharmaceuticals Inc Compostos e método para tratar a síndrome de liberação de citocinas
CN121159524A (zh) * 2019-08-30 2025-12-19 里格尔药品股份有限公司 吡唑化合物，其配制品以及使用所述化合物和/或配制品的方法
JP2025513716A (ja) * 2022-03-23 2025-04-30 ライジェル・ファーマシューティカルズ・インコーポレイテッド Ｉｒａｋ阻害剤としてのピリミド－２－イル－ピラゾール化合物
CN121270516A (zh) * 2024-07-03 2026-01-06 科辉智药(深圳)新药研究中心有限公司 一种irak抑制剂化合物的晶型及其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008526723A (ja) 2004-12-30 2008-07-24 アステックス、セラピューティックス、リミテッド Ｃｄｋ、ｇｓｋ及びオーロラキナーゼの活性を調節するピラゾール誘導体
WO2011043371A1 (ja) 2009-10-07 2011-04-14 アステラス製薬株式会社 オキサゾール化合物

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4921475A (en) 1983-08-18 1990-05-01 Drug Delivery Systems Inc. Transdermal drug patch with microtubes
US5087240A (en) 1983-08-18 1992-02-11 Drug Delivery Systems Inc. Transdermal drug patch with conductive fibers
US4738851A (en) 1985-09-27 1988-04-19 University Of Iowa Research Foundation, Inc. Controlled release ophthalmic gel formulation
US5163899A (en) 1987-03-20 1992-11-17 Drug Delivery Systems Inc. Transdermal drug delivery system
US5312325A (en) 1987-05-28 1994-05-17 Drug Delivery Systems Inc Pulsating transdermal drug delivery system
GB8804164D0 (en) 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US4882150A (en) 1988-06-03 1989-11-21 Kaufman Herbert E Drug delivery system
US5008110A (en) 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5088977A (en) 1988-12-21 1992-02-18 Drug Delivery Systems Inc. Electrical transdermal drug applicator with counteractor and method of drug delivery
US5521222A (en) 1989-09-28 1996-05-28 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
EP0431519B1 (en) 1989-12-04 1994-06-15 G.D. Searle & Co. System for transdermal albuterol administration
US5077033A (en) 1990-08-07 1991-12-31 Mediventures Inc. Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide
ATE141502T1 (de) 1991-01-15 1996-09-15 Alcon Lab Inc Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen
US5352456A (en) 1991-10-10 1994-10-04 Cygnus Therapeutic Systems Device for administering drug transdermally which provides an initial pulse of drug
DE69228827T2 (de) 1991-12-18 1999-10-21 Minnesota Mining And Mfg. Co., Saint Paul Mehrschichtige sperrstrukturen
EP0553769B1 (de) 1992-01-29 1996-01-03 FRANZ VÖLKL GmbH & CO. SKI UND TENNIS SPORTARTIKELFABRIK KG Ballspielschläger, insbesondere Tennisschläger
IL114193A (en) 1994-06-20 2000-02-29 Teva Pharma Ophthalmic pharmaceutical compositions based on sodium alginate
ES2094688B1 (es) 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
IT1283911B1 (it) 1996-02-05 1998-05-07 Farmigea Spa Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
US5800807A (en) 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
US6197934B1 (en) 1998-05-22 2001-03-06 Collagenesis, Inc. Compound delivery using rapidly dissolving collagen film
CA2964982C (en) 2014-11-20 2022-07-05 Merck Patent Gmbh Heteroaryl compounds as irak inhibitors and uses thereof
EA039043B1 (ru) * 2015-04-22 2021-11-25 Райджел Фармасьютикалз, Инк. Пиразольные соединения и способ получения и применения данных соединений
JP2019196309A (ja) * 2016-09-15 2019-11-14 武田薬品工業株式会社 複素環化合物

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008526723A (ja) 2004-12-30 2008-07-24 アステックス、セラピューティックス、リミテッド Ｃｄｋ、ｇｓｋ及びオーロラキナーゼの活性を調節するピラゾール誘導体
WO2011043371A1 (ja) 2009-10-07 2011-04-14 アステラス製薬株式会社 オキサゾール化合物

Also Published As

Publication number Publication date
CN110099899B (zh) 2024-01-02
CA3041587A1 (en) 2018-05-17
US20190300518A1 (en) 2019-10-03
DK3532470T3 (da) 2023-02-20
EP3532470B1 (en) 2022-12-07
US10370367B2 (en) 2019-08-06
JP7379640B2 (ja) 2023-11-14
US20180111923A1 (en) 2018-04-26
US20210179601A1 (en) 2021-06-17
JP2023011795A (ja) 2023-01-24
US20230062818A1 (en) 2023-03-02
ES2939232T3 (es) 2023-04-20
EP3532470A1 (en) 2019-09-04
WO2018089199A1 (en) 2018-05-17
US11993594B2 (en) 2024-05-28
CN110099899A (zh) 2019-08-06
PT3532470T (pt) 2023-02-28
JP2019537577A (ja) 2019-12-26
US11492349B2 (en) 2022-11-08
US10941140B2 (en) 2021-03-09

Similar Documents

Publication Publication Date Title
JP7379639B2 (ja) キナーゼ阻害剤ならびに作製および使用のための方法
JP7339997B2 (ja) ベンズアゾール化合物ならびに該化合物の作製方法および使用方法
JP7187729B2 (ja) Ｒｉｐ１阻害剤化合物並びにそれを製造及び使用するための方法
JP7065840B2 (ja) ２，４－ジアミノ－ピリミジン化合物ならびに該化合物の作製法および使用法
JP7379641B2 (ja) Ｉｒａｋ阻害剤としてのピラゾールアミド化合物
EP4025572A1 (en) Heterocyclic rip1 kinase inhibitors
JP7379640B2 (ja) Ｉｒａｋ阻害剤としての使用のためのオキサゾール誘導体およびその調製のための方法
HK40013639A (en) Oxazole derivatives for use as irak inhibitors and method for their preparation
HK40013639B (en) Oxazole derivatives for use as irak inhibitors and method for their preparation
HK40013987B (en) Pyrazole amide compounds as irak inhibitors
HK40013987A (en) Pyrazole amide compounds as irak inhibitors

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190529

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201023

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201023

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20210326

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20210922

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211011

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220106

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220525

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220725

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20221003

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20221101

R150 Certificate of patent or registration of utility model

Ref document number: 7170634

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250